These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8251619)

  • 21. Pharmacokinetical modelling: clinical applications.
    Rucquoi M
    Acta Anaesthesiol Belg; 1988; 39(3 Suppl 2):223-5. PubMed ID: 3176857
    [No Abstract]   [Full Text] [Related]  

  • 22. [Pharmacokinetics in the aged subject].
    Hirtz J
    Pharm Acta Helv; 1980; 55(3):72-8. PubMed ID: 6994126
    [No Abstract]   [Full Text] [Related]  

  • 23. Physicochemical interpretation of the pharmacokinetics of percutaneous absorption.
    Guy RH; Hadgraft J
    J Pharmacokinet Biopharm; 1983 Apr; 11(2):189-203. PubMed ID: 6886974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determination of drug absorption rate in time-variant disposition by direct deconvolution using beta clearance correction and end-constrained non-parametric regression.
    Neelakantan S; Veng-Pedersen P
    Biopharm Drug Dispos; 2005 Nov; 26(8):353-70. PubMed ID: 16088968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concepts basic to pharmacokinetics.
    Tozer TN
    Pharmacol Ther; 1981; 12(1):109-31. PubMed ID: 7255535
    [No Abstract]   [Full Text] [Related]  

  • 26. Physiologically Based Pharmacokinetic (PBPK) Modeling of Pharmaceutical Nanoparticles.
    Li M; Zou P; Tyner K; Lee S
    AAPS J; 2017 Jan; 19(1):26-42. PubMed ID: 27834047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and their clinical significance.
    Garrett ER
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):193-6. PubMed ID: 5357862
    [No Abstract]   [Full Text] [Related]  

  • 28. Measurement of disposition half-life, clearance, and residence times.
    Mayersohn M
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit5.3. PubMed ID: 20949436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical pharmacokinetics--theoretical bases].
    van Ginneken CA; Koopmans PP
    Ned Tijdschr Geneeskd; 1986 Jan; 130(2):54-9. PubMed ID: 3951590
    [No Abstract]   [Full Text] [Related]  

  • 30. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graphic methods in pharmacokinetics: the basics.
    Welling PG
    J Clin Pharmacol; 1986; 26(7):510-4. PubMed ID: 3760243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Derivation of Laplace transform for the general disposition deconvolution equation in drug metabolism kinetics.
    Popović J
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):409-11. PubMed ID: 10445406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
    Zhang Q; Wang GJ
    Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physiological pharmacokinetics.
    Bischoff KB
    Bull Math Biol; 1986; 48(3-4):309-22. PubMed ID: 3828560
    [No Abstract]   [Full Text] [Related]  

  • 35. Expert Discussion of the Role of Rate Constant Versus Clearance Approaches to Define Drug Pharmacokinetics: Theoretical and Clinical Considerations.
    Martinez MN; Jelliffe RW; Proost JH
    AAPS J; 2020 Jan; 22(2):25. PubMed ID: 31907706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PHRMA CPCDC initiative on predictive models of human pharmacokinetics, part 5: prediction of plasma concentration-time profiles in human by using the physiologically-based pharmacokinetic modeling approach.
    Poulin P; Jones RD; Jones HM; Gibson CR; Rowland M; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Yates JW
    J Pharm Sci; 2011 Oct; 100(10):4127-57. PubMed ID: 21541937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The method of statistical moments and the integral model-independent parameters of pharmacokinetics].
    Piotrovskiĭ VK
    Farmakol Toksikol; 1986; 49(5):118-27. PubMed ID: 3533616
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimal perfusion rate determined for in situ intestinal absorption studies in rats.
    Savina PM; Staubus AE; Gaginella TS; Smith DF
    J Pharm Sci; 1981 Mar; 70(3):239-43. PubMed ID: 7264883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calculation of oral absorption over short time intervals using clearance and constant blood withdrawal.
    Kowarski CR; Kowarski AA
    Pharm Acta Helv; 1980; 55(5):141-3. PubMed ID: 7403197
    [No Abstract]   [Full Text] [Related]  

  • 40. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.